Insider · CIK 0001918845
Mittie Doyle
Files at AVTX (Avalo Therapeutics, Inc.), CGEM (Cullinan Therapeutics, Inc.). First filing Mar 18, 2026, latest Sep 1, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AVTX: Avalo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Avalo Therapeutics, Inc. | $14k 679 shares | -1% | +117% from low-14% from high | |
| 16Weak | Avalo Therapeutics, Inc. | $412k 25,492 shares | -88% | +346% from low-20% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +679 | $8.04 | $5,459 | 52,455 | 41 d ago |
| Aug 28, 2026 | AVTX Avalo Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -679 | $20.00 | $14k | 51,776 | 41 d ago |
| Aug 28, 2026 | AVTX Avalo Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -679 | $0.00 | $0 | 113,734 | 41 d ago |
| Mar 16, 2026 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +19,500 | $12.65 | $247k | 23,122 | Mar 18, 2026 |
| Mar 16, 2026 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,992 | $8.04 | $48k | 29,114 | Mar 18, 2026 |
| Mar 16, 2026 | AVTX Avalo Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,492 | $16.15 | $412k | 3,622 | Mar 18, 2026 |
| Mar 16, 2026 | AVTX Avalo Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -19,500 | $0.00 | $0 | 214,500 | Mar 18, 2026 |
| Mar 16, 2026 | AVTX Avalo Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,992 | $0.00 | $0 | 149,008 | Mar 18, 2026 |
| Feb 26, 2026 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Mar 2, 2026 |
| Dec 10, 2025 | AVTX Avalo Therapeutics, Inc. | FTax withholding Common Stock | -1,013 | $4.10 | $4,153 | 3,622 | Dec 12, 2025 |
| Aug 7, 2025 | CGEM Cullinan Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +79,456 | $0.00 | $0 | 79,456 | Aug 8, 2025 |
| Jan 28, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +155,000 | $0.00 | $0 | 155,000 | Jan 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.